American Conference of Pharmacometrics: “Modeling without Bounds.”
San Diego, CA
Jin Dong, Ke Szeto, Marv Waldman, Jill Fiedler-Kelly, Joel Owen, Yogesh Patel, and Nikita Parab, Elizabeth Ludwig, Luann Phillips, and David Jawarowicz will be exhibiting in booths #1 & 2.
An ACoP9 pre-meeting workshop will be held on Saturday, October 6, entitled: Using DILIsym to Assess the Liver Safety of Drugs and Drug Candidates.
We’ll also host an ACoP9 post-meeting workshop entitled, Extending MAM/PBPK modeling approaches to predict non-oral delivery of drugs.
Jill Fiedler-Kelly and Yogesh Patel are Co-Chairs of the Sessions 6c symposium entitled Effective Communication of Covariate Effects on Wednesday October 10th.
Keynote Lecture – Walter Woltosz : Rocket motors, Stephen Hawking, and drug development
Representation of Crizotinib and Pazopanib-mediated DrugInduced Liver Injury (DILI) Using Quantitative Systems Toxicology (QST)
M-068 – Monday PM
Concentration-QT Analysis of Quizartinib in Patients with Relapsed/Refractory AML
M-044 – Monday PM
Development of a Physiologically Based Pharmacokinetic Model for Losartan and Its Active Metabolite E3174 – Ethnic Differences in Pharmacokinetics between Caucasian and Asian Populations
T-021 – Tuesday AM
Quantitative Systems Toxicology Modeling Using DILIsym Suggests That Mitochondrial Biogenesis Could Explain Adaptation to Drug-Induced Liver Injury
T-050 Tuesday PM
A Model-based Approach to Bridging Plasma and Dried Blood Spot Concentration Data for Phase 3 Verubecestat Trials
T-064 – Tuesday PM
Direct Activation of CD8+ T Cells in the Context of Amodiaquine-Induced Liver Injury Advances Groundwork for Mathematical Representation of Idiosyncratic Drug-Induced Liver Injury (iDILI)
W-076 – Wednesday PM
Using DILIsym to Assess the Liver Safety of Drugs and Drug Candidates
Saturday, October 6 @ 8:30AM to 5:00PM
Extending MAM/PBPK modeling approaches to predict non‐oral delivery of drugs
Friday, October 12th @ 8:30 AM to 5:00 PM